About US
Contact us
-
England's NHS waged a tense behind-the-scenes fight against pricey hep C drugsWhen England’s cost-effectiveness gatekeepers gave their blessing to Gilead Sciences’ pricey hepatitis C drugs last year, some of the country’s sickest patients were already being treated under a spec2016/8/16
-
FDA amps up black-box warnings on antibiotic class that includes J&J's Levaquin, Bayer's CiproThe FDA stepped up warnings on antibiotics like Johnson & Johnson’s Levaquin, adding long-term risks to the drugs’ current black-box warning. The agency also advised using the drugs only for serio2016/8/15
-
BMS' Opdivo, Amgen's Repatha first on Japan's list for new price restrictionsPharma, already smarting in Japan from new price controls imposed by the government, may now face additional limits on new breakthrough drugs. Up first for challenge are Bristol-Myers Squibb’s hot-sel2016/8/15
-
M&As this week: Arterium Corporation, Guanhao BiotechOriginal and generic pharmaceutical product providerArterium Corporationhas acquired pharmaceutical company Marifarm from Novo KBM d,d. to strengthen its research and development (R&D) and product2016/8/12
-
Janssen’s Imbruvica receives SMC recommendation for blood cancer treatmentThe Scottish Medicines Consortium (SMC) has recommended pharmaceutical company Janssen’s Imbruvica (ibrutinib) treatment for use in Scottish patients with specific types of rare and aggressive blood c2016/8/12
-
New study reveals warfarin may be ineffective for atrial fibrillation over long-termA study conducted by US-based Duke Clinical Research Institute researchers has revealed that warfarin, a drug prescribed to prevent strokes in patients with atrial fibrillation, may not be able to ade2016/8/11
-
NMRC and WRAIR develop personalised phage cocktails to treat antibiotic-resistant infectionA team from US Naval Medical Research Centre (NMRC) and Maryland’s Walter Reed Army Institute of Research (WRAIR) has been successful in using bacteriophage therapy to fight an antibiotic-resistant in2016/8/11
-
UPDATED: California snares $30M in Bristol-Myers kickbacks case featuring luxury golf, lavish dinners and Lakers campGolf outings at top courses. Box suites at sporting events. A Los Angeles Lakers basketball camp. And the usual “lavish dinners.” They all figured into a California crackdown on Bristol-Myers Squibb’s2016/8/10
-
Shareholders sue struggling Perrigo for 'misleading' them away from Mylan buySince dodging a hostile buyout attempt from generics maker Mylan, Perrigo hasn’t been doing so hot. And some of the company’s shareholders aren’t pleased. Investors have filed a class action lawsuit2016/8/10
-
New research reveals alcohol abuse control drug can treat blinding disorderNew research has revealed that the drug known asdisulfiram, which is licensed for the control of alcohol abuse, can be used to prevent conjunctival scarring and treat a blinding disorder. Disulfiram2016/8/9